Rechercher

Ajouter une nouvelle offre d'emploi Autre

2026-05-12 17:04:42 -

Rising Prevalence of Breast Cancer Drives Growth in the HER2 Testing Market

As of May 2026, the Human Epidermal Growth Factor Receptor 2 (HER2) Testing Market is undergoing a pivotal expansion. No longer confined to a binary "positive" or "negative" result, the industry is transitioning toward precision subtyping, including the identification of "HER2-low" populations. This shift is driven by the regulatory approval of advanced antibody-drug conjugates (ADCs) like...

0 Commentaires 0 Parts 204 Vue 0 Aperçu

#her2_testing_market